SLU-PP-332 1000mcg

Description

SLU-PP-332 1mg — the threshold dose where ERR agonism moves from exploratory to functionally impactful for trained individuals. At this level, the compound’s effects on mitochondrial biogenesis, fat oxidation enzyme expression, and muscle fibre phenotype are meaningfully engaged, with research protocols at this dose demonstrating significant improvements in aerobic capacity, fat oxidation rates, and the metabolic gene expression profile that characterises endurance-adapted muscle. The combination of maximum mitochondrial density drive and fatty acid oxidation upregulation at 1mg produces a measurable substrate shift — more calories burned from fat, more efficient oxygen utilisation, and greater endurance capacity across training sessions. For athletes combining SLU-PP-332 with structured cardiovascular training, this dose amplifies the training adaptation signal in ways that pure pharmacology or pure training alone cannot replicate. This is the compound that makes exercise more efficient at the cellular level. Verified at 99%+ purity by Puralytix. Daily administration is important for consistent ERR pathway engagement. At 1mg, the compound’s gene expression effects in skeletal muscle are producing the most significant mitochondrial density and fatty acid oxidation enzyme changes achievable. Morning administration before aerobic training may enhance the synergy between circadian metabolic gene expression patterns and exercise-driven adaptation.